Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Bellile

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
JAMA Otolaryngology-- Head & Neck Surgery|February 3, 2017
Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal CancerGregory T Wolf, Emily Bellile, Avraham Eisbruch, et al.
BMC Cancer|November 1, 2015
NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomasShama Virani, Emily Bellile, Carol R Bradford, et al.
Oncotarget|July 1, 2021
Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinomaCatherine T Haring, Chandan Bhambhani, Collin Brummel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 10, 2021
Phosphorylation of TRIP13 at Y56 induces radiation resistance but sensitizes head and neck cancer to cetuximabRajat Banerjee, Min Liu, Emily Bellile, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2024
Phase II Clinical Trial of Intravenous Levothyroxine to Mitigate Pharyngocutaneous Fistula in Euthyroid Patients Undergoing Salvage LaryngectomyMolly E Heft Neal, Catherine T Haring, Emily Bellile, et al.
Oncoimmunology|December 3, 2021
Cancer-specific type-I interferon receptor signaling promotes cancer stemness and effector CD8+ T-cell exhaustionWang Gong, Christopher R Donnelly, Blake R Heath, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 20, 2016
Exploration for an Algorithm for Deintensification to Exclude the Retropharyngeal Site From Advanced Oropharyngeal Squamous Cell Carcinoma TreatmentMatthew E Spector, Steven B Chinn, Emily Bellile, et al.
Nature Communications|August 1, 2014
TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancerRajat Banerjee, Nickole Russo, Min Liu, et al.
Nature Communications|February 25, 2016
Corrigendum: TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancerRajat Banerjee, Nickole Russo, Min Liu, et al.
Head & Neck|September 25, 2014
Matted nodes as a predictor of distant metastasis in advanced-stage III/IV oropharyngeal squamous cell carcinomaMatthew E Spector, Steven B Chinn, Emily Bellile, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
JAMA Otolaryngology-- Head & Neck Surgery|February 3, 2017
Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal CancerGregory T Wolf, Emily Bellile, Avraham Eisbruch, et al.
BMC Cancer|November 1, 2015
NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomasShama Virani, Emily Bellile, Carol R Bradford, et al.
Oncotarget|July 1, 2021
Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinomaCatherine T Haring, Chandan Bhambhani, Collin Brummel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 10, 2021
Phosphorylation of TRIP13 at Y56 induces radiation resistance but sensitizes head and neck cancer to cetuximabRajat Banerjee, Min Liu, Emily Bellile, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2024
Phase II Clinical Trial of Intravenous Levothyroxine to Mitigate Pharyngocutaneous Fistula in Euthyroid Patients Undergoing Salvage LaryngectomyMolly E Heft Neal, Catherine T Haring, Emily Bellile, et al.
Oncoimmunology|December 3, 2021
Cancer-specific type-I interferon receptor signaling promotes cancer stemness and effector CD8+ T-cell exhaustionWang Gong, Christopher R Donnelly, Blake R Heath, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 20, 2016
Exploration for an Algorithm for Deintensification to Exclude the Retropharyngeal Site From Advanced Oropharyngeal Squamous Cell Carcinoma TreatmentMatthew E Spector, Steven B Chinn, Emily Bellile, et al.
Nature Communications|August 1, 2014
TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancerRajat Banerjee, Nickole Russo, Min Liu, et al.
Nature Communications|February 25, 2016
Corrigendum: TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancerRajat Banerjee, Nickole Russo, Min Liu, et al.
Head & Neck|September 25, 2014
Matted nodes as a predictor of distant metastasis in advanced-stage III/IV oropharyngeal squamous cell carcinomaMatthew E Spector, Steven B Chinn, Emily Bellile, et al.
Pageof 8